Woo Kyu Jeon
Overview
Explore the profile of Woo Kyu Jeon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
1756
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sohn W, Ham C, Kim N, Kim H, Cho Y, Jeon W, et al.
PLoS One
. 2020 Dec;
15(12):e0243780.
PMID: 33315944
The purpose of this study was to investigate the effect of acute kidney injury (AKI) on the prognosis of patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE). A total...
2.
Kim M, Lee J, Kim J, Kim H, Cho Y, Jeon W, et al.
PLoS One
. 2020 Oct;
15(10):e0240195.
PMID: 33095789
This study aimed to investigate the relationship between serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). A cross-sectional study was conducted using nationally representative...
3.
Kim J, Choi S, Park T, Kim S, Jung Y, Park J, et al.
Intest Res
. 2018 Nov;
17(2):253-264.
PMID: 30449080
Background/aim: Colorectal cancer incidence among patients aged ≤50 years is increasing. This study aimed to develop and validate an advanced colorectal neoplasm (ACRN) screening model for young adults aged <50...
4.
Kim N, Jung Y, Hong H, Park J, Kim H, Park D, et al.
Liver Int
. 2018 Jan;
38(8):1487-1494.
PMID: 29359396
Background & Aims: The relationship between cigarette smoking and nonalcoholic fatty liver disease (NAFLD) has been controversial. Most relevant studies have relied on self-reported questionnaires. We aimed to elucidate the...
5.
Jung H, Kim B, Cho Y, Jeon W, Kim H, Hong H
Clin Mol Hepatol
. 2017 Nov;
24(4):424-429.
PMID: 29132204
Hepatocellular carcinoma (HCC) is the sixth most common cause of death worldwide and the main cause of primary liver cancer. The principle problem of HCC is the poor prognosis, since...
6.
Kim H, Cho Y, Jeon W, Kim B
Clin Mol Hepatol
. 2017 Sep;
23(4):323-330.
PMID: 28870025
Background/aims: Clinical characteristics of patients with chronic hepatitis B (CHB) who developed genotypic resistance to entecavir (ETV) were compared to those without resistance. Methods: Two hundred fifty eight CHB patients...
7.
Lee T, Kim H, Park S, Yang H, Jung Y, Park J, et al.
Langenbecks Arch Surg
. 2017 Mar;
402(3):429-437.
PMID: 28255733
Purpose: The study was done to elucidate the clinico-radiologic predictive factors for cancerous change detected by disease progression (PD) mainly defined by interval increase in cyst size and change of...
8.
Kim J, Do I, Kim K, Sohn J, Kim H, Jeon W, et al.
Cancer Chemother Pharmacol
. 2016 Oct;
78(5):1085-1092.
PMID: 27744566
Purpose: Progranulin (PGRN), characterized as an autocrine growth and survival factor, is known to stimulate the proliferation and survival of several cancer cell types. However, little is known about the...
9.
Kim H, Park S, Yang H, Jung Y, Park J, Park D, et al.
Clin Mol Hepatol
. 2016 Oct;
22(3):350-358.
PMID: 27729626
Background/aims: To analyze the effects of preexisting lamivudine (LAM) resistance and applying antiviral treatment (adefovir [ADV] add-on LAM combination treatment) on long-term treatment outcomes, and comparing the clinical outcomes of...
10.
Kim J, Park D, Yu J, Jung Y, Park J, Kim H, et al.
Clin Gastroenterol Hepatol
. 2016 Apr;
14(9):1310-1316.e2.
PMID: 27108793
Background & Aims: Obesity and metabolic abnormality are risk factors for colorectal cancer and adenoma. We evaluated the risk of advanced colorectal neoplasm (AN) according to metabolic status and obesity...